CTSF has emerged as a potential disease biomarker and therapeutic target
also known as AMHRII (anti-Mullerian hormone type II receptor)
making it a potential biomarker and therapeutic target in cancer and metabolic diseases
It is involved in the activation and recruitment of immune cells to sites of injury or infection
Mutations in the LMNA gene can lead to a group of diseases known as laminopathies
CD206 Recombinant Rabbit mAb (S-3477-27) Size:100μl CTSF has emerged as aProduct Specification Host Rabbit Antigen CD206 Synonyms Macrophage mannose receptor 1; MMR; Mrc1 Immunogen Synthetic Peptide Location Endosome, Cell membrane Accession Q61830 Clone Number S 3477 27 Antibody Type Recombinant mAb Isotype IgG Application WB, IHC P Reactivity Hu, Ms, Rt Positive Sample PMA, IL 4 and Brefeldin A treated THP 1, mouse liver, mouse lung, mouse spleen, rat liver, rat lung, rat spleen Purification Protein A Concentration 0. 5